Proteome Sciences (GB:PRM) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Proteome Sciences has reported a dip in revenues and gross profit in H1 2024 compared to the previous year but anticipates a resurgence in orders following the launch of their new TMTpro 35plex tags. The company is optimistic about returning to growth with increased orders in Q3 and the development of their innovative plexDIA tags, which are entering licensing discussions. Additionally, their U.S. lab has begun delivering projects, and a CEO transition is underway with Dr. Mariola Soehngen stepping down in January 2025.
For further insights into GB:PRM stock, check out TipRanks’ Stock Analysis page.